Researchers have developed a GlyT2 blocker that alleviates chronic neuropathic pain without major side effects, offering a non-addictive alternative to opioids.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
New GlyT2 blocker relieves chronic neuropathic pain without major side effects
Rensselaer Polytechnic Institute, University Of Sydney, Univ Research institutions
Chronic Neuropathic Pain Condition targeted
Non-Addictive, Major Side Effect-Free Pain Relief Key advantage